vs
Astrana Health, Inc.（ASTH）与PennyMac Financial Services, Inc.（PFSI）财务数据对比。点击上方公司名可切换其他公司
Astrana Health, Inc.的季度营收约是PennyMac Financial Services, Inc.的1.8倍（$950.5M vs $538.0M），PennyMac Financial Services, Inc.净利率更高（1752.5% vs 0.7%，领先1751.8%），Astrana Health, Inc.同比增速更快（42.9% vs 14.4%），Astrana Health, Inc.自由现金流更多（$-6.0M vs $-1.7B），过去两年Astrana Health, Inc.的营收复合增速更高（53.3% vs 32.7%）
Astrana Health是一家总部位于美国的价值导向型医疗服务提供商，主要服务全美符合联邦医保资格的老年群体，提供上门初级护理、慢性病管理及护理协调服务，致力于提升患者健康水平、降低不必要的医疗支出。
PennyMac Financial Services是总部位于美国加利福尼亚州西湖村的住宅抵押贷款企业，核心业务涵盖美国抵押贷款的发放、贷后服务，以及抵押贷款市场相关投资管理。公司下设两家子公司，其中PNMAC资本管理有限公司负责运营旗下的抵押贷款不动产投资信托（REIT）PennyMac Mortgage Investment Trust。
ASTH vs PFSI — 直观对比
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $950.5M | $538.0M |
| 净利润 | $6.6M | $106.8M |
| 毛利率 | — | — |
| 营业利润率 | 1.9% | 25.0% |
| 净利率 | 0.7% | 1752.5% |
| 营收同比 | 42.9% | 14.4% |
| 净利润同比 | 184.4% | 2.2% |
| 每股收益（稀释后） | $0.12 | $1.97 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
| Q4 25 | $950.5M | $538.0M | ||
| Q3 25 | $956.0M | $632.9M | ||
| Q2 25 | $654.8M | $444.7M | ||
| Q1 25 | $620.4M | $430.9M | ||
| Q4 24 | $665.2M | $470.1M | ||
| Q3 24 | $478.7M | $411.8M | ||
| Q2 24 | $486.3M | $406.1M | ||
| Q1 24 | $404.4M | $305.7M |
| Q4 25 | $6.6M | $106.8M | ||
| Q3 25 | $373.0K | $181.5M | ||
| Q2 25 | $9.4M | $136.5M | ||
| Q1 25 | $6.7M | $76.3M | ||
| Q4 24 | $-7.8M | $104.5M | ||
| Q3 24 | $16.1M | $69.4M | ||
| Q2 24 | $19.2M | $98.3M | ||
| Q1 24 | $14.8M | $39.3M |
| Q4 25 | 1.9% | 25.0% | ||
| Q3 25 | 2.0% | 37.3% | ||
| Q2 25 | 3.1% | 17.2% | ||
| Q1 25 | 3.3% | 24.2% | ||
| Q4 24 | 0.1% | 27.5% | ||
| Q3 24 | 5.9% | 22.8% | ||
| Q2 24 | 6.2% | 33.0% | ||
| Q1 24 | 7.5% | 14.4% |
| Q4 25 | 0.7% | 1752.5% | ||
| Q3 25 | 0.0% | 28.7% | ||
| Q2 25 | 1.4% | 30.7% | ||
| Q1 25 | 1.1% | 17.7% | ||
| Q4 24 | -1.2% | 2559.8% | ||
| Q3 24 | 3.4% | 16.8% | ||
| Q2 24 | 3.9% | 24.2% | ||
| Q1 24 | 3.7% | 12.9% |
| Q4 25 | $0.12 | $1.97 | ||
| Q3 25 | $0.01 | $3.37 | ||
| Q2 25 | $0.19 | $2.54 | ||
| Q1 25 | $0.14 | $1.42 | ||
| Q4 24 | $-0.14 | $1.95 | ||
| Q3 24 | $0.33 | $1.30 | ||
| Q2 24 | $0.40 | $1.85 | ||
| Q1 24 | $0.31 | $0.74 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $429.5M | $410.0M |
| 总债务越低越好 | — | $6.2B |
| 股东权益账面价值 | $779.3M | $4.3B |
| 总资产 | $2.2B | $29.4B |
| 负债/权益比越低杠杆越低 | — | 1.45× |
8季度趋势，按日历期对齐
| Q4 25 | $429.5M | $410.0M | ||
| Q3 25 | $463.4M | $62.2M | ||
| Q2 25 | $342.1M | $462.3M | ||
| Q1 25 | $260.9M | $443.4M | ||
| Q4 24 | $290.8M | $420.6M | ||
| Q3 24 | $350.3M | $667.9M | ||
| Q2 24 | $327.7M | $188.8M | ||
| Q1 24 | $337.3M | $69.0K |
| Q4 25 | — | $6.2B | ||
| Q3 25 | — | $6.2B | ||
| Q2 25 | — | $5.6B | ||
| Q1 25 | — | $5.8B | ||
| Q4 24 | — | $5.3B | ||
| Q3 24 | — | $4.9B | ||
| Q2 24 | — | $4.9B | ||
| Q1 24 | — | $4.5B |
| Q4 25 | $779.3M | $4.3B | ||
| Q3 25 | $775.5M | $4.2B | ||
| Q2 25 | $765.5M | $4.0B | ||
| Q1 25 | $745.4M | $3.9B | ||
| Q4 24 | $712.7M | $3.8B | ||
| Q3 24 | $704.6M | $3.7B | ||
| Q2 24 | $678.9M | $3.7B | ||
| Q1 24 | $653.5M | $3.6B |
| Q4 25 | $2.2B | $29.4B | ||
| Q3 25 | $2.2B | $25.4B | ||
| Q2 25 | $1.4B | $24.2B | ||
| Q1 25 | $1.3B | $23.9B | ||
| Q4 24 | $1.4B | $26.1B | ||
| Q3 24 | $1.3B | $22.9B | ||
| Q2 24 | $1.3B | $21.6B | ||
| Q1 24 | $1.2B | $19.8B |
| Q4 25 | — | 1.45× | ||
| Q3 25 | — | 1.48× | ||
| Q2 25 | — | 1.38× | ||
| Q1 25 | — | 1.48× | ||
| Q4 24 | — | 1.37× | ||
| Q3 24 | — | 1.32× | ||
| Q2 24 | — | 1.35× | ||
| Q1 24 | — | 1.27× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-2.9M | $-1.7B |
| 自由现金流经营现金流 - 资本支出 | $-6.0M | $-1.7B |
| 自由现金流率自由现金流/营收 | -0.6% | -309.3% |
| 资本支出强度资本支出/营收 | 0.3% | 2.2% |
| 现金转化率经营现金流/净利润 | -0.44× | -15.46× |
| 过去12个月自由现金流最近4个季度 | $104.5M | $-1.4B |
8季度趋势，按日历期对齐
| Q4 25 | $-2.9M | $-1.7B | ||
| Q3 25 | $10.0M | $-697.4M | ||
| Q2 25 | $90.9M | $-131.3M | ||
| Q1 25 | $16.6M | $1.1B | ||
| Q4 24 | $-10.9M | $-4.5B | ||
| Q3 24 | $34.0M | $-393.7M | ||
| Q2 24 | $23.2M | $-1.1B | ||
| Q1 24 | $6.0M | $-897.9M |
| Q4 25 | $-6.0M | $-1.7B | ||
| Q3 25 | $7.4M | $-699.4M | ||
| Q2 25 | $89.5M | $-132.6M | ||
| Q1 25 | $13.6M | $1.1B | ||
| Q4 24 | $-13.5M | $-4.5B | ||
| Q3 24 | $31.7M | $-393.9M | ||
| Q2 24 | $20.4M | $-1.1B | ||
| Q1 24 | $5.6M | $-898.9M |
| Q4 25 | -0.6% | -309.3% | ||
| Q3 25 | 0.8% | -110.5% | ||
| Q2 25 | 13.7% | -29.8% | ||
| Q1 25 | 2.2% | 247.3% | ||
| Q4 24 | -2.0% | -964.7% | ||
| Q3 24 | 6.6% | -95.6% | ||
| Q2 24 | 4.2% | -269.2% | ||
| Q1 24 | 1.4% | -294.1% |
| Q4 25 | 0.3% | 2.2% | ||
| Q3 25 | 0.3% | 0.3% | ||
| Q2 25 | 0.2% | 0.3% | ||
| Q1 25 | 0.5% | 0.1% | ||
| Q4 24 | 0.4% | 0.4% | ||
| Q3 24 | 0.5% | 0.0% | ||
| Q2 24 | 0.6% | 0.1% | ||
| Q1 24 | 0.1% | 0.3% |
| Q4 25 | -0.44× | -15.46× | ||
| Q3 25 | 26.69× | -3.84× | ||
| Q2 25 | 9.65× | -0.96× | ||
| Q1 25 | 2.48× | 13.97× | ||
| Q4 24 | — | -43.39× | ||
| Q3 24 | 2.11× | -5.68× | ||
| Q2 24 | 1.21× | -11.12× | ||
| Q1 24 | 0.40× | -22.84× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ASTH
| Medicare | $542.4M | 57% |
| Commercial | $99.1M | 10% |
| Care Delivery | $92.1M | 10% |
| Care Enablement | $78.9M | 8% |
| Other Third Parties | $58.0M | 6% |
| Health Care Patient Service | $39.8M | 4% |
| Health Care Other | $25.5M | 3% |
| Other | $12.1M | 1% |
| Management Service | $10.3M | 1% |
PFSI
暂无分部数据
